CTI Partners II, L.P.

All filings by CTI Partners II, L.P. on record concern IMV Inc. (formerly Immunovaccine Inc.). In total, 3 filings cover trades dated from 8 June 2018 to 12 June 2018.

Every open-market trade on record is a sale: 1 sale worth €7,325. Other entries cover 2 option exercises.

The record was last updated on 14 June 2018 with an open-market sale (€7,325) in IMV Inc. (formerly Immunovaccine Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 3 days. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.